Cholecystokinin, β-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls

Massimo C. Mauri, Renata Rudelli, Stefano Vanni, Gabriele Panza, Aldo Sicaro, Daniele Audisio, Paola Sacerdote, Alberto E. Panerai

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cholecystokinin (CCK), β-endorphin (BE), and vasoactive intestinal peptide (VIP) in peripheral blood mononuclear cells from 30 drug-naive schizophrenics compared to 22 healthy controls were studied. Patients were evaluated with the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Positive Symptoms (SAPS) and the Scale for the Assessment of the Negative Symptoms (SANS) at baseline (TO), and after four weeks (T4) in nine patients who were subsequently treated with haloperidol (HL). Neuropeptide concentrations in peripheral blood mononuclear cells (PBMC) were measured at T0 and, for the treated patients, at T4. There was a negative correlation between CCK and SANS baseline scores and a trend for patients who responded poorly to HL (i.e. patients with a prevalence of negative symptomatology) to have lower CCK basal values.

Original languageEnglish
Pages (from-to)45-50
Number of pages6
JournalPsychiatry Research
Volume78
Issue number1-2
DOIs
Publication statusPublished - Mar 20 1998

Fingerprint

Endorphins
Vasoactive Intestinal Peptide
Cholecystokinin
Haloperidol
Blood Cells
Pharmaceutical Preparations
Symptom Assessment
Brief Psychiatric Rating Scale
Neuropeptides

Keywords

  • β-Endorphin
  • Cholecystokinin
  • Haloperidol
  • Schizophrenia
  • Vasoactive intestinal peptide

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Psychology(all)

Cite this

Cholecystokinin, β-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls. / Mauri, Massimo C.; Rudelli, Renata; Vanni, Stefano; Panza, Gabriele; Sicaro, Aldo; Audisio, Daniele; Sacerdote, Paola; Panerai, Alberto E.

In: Psychiatry Research, Vol. 78, No. 1-2, 20.03.1998, p. 45-50.

Research output: Contribution to journalArticle

Mauri, Massimo C. ; Rudelli, Renata ; Vanni, Stefano ; Panza, Gabriele ; Sicaro, Aldo ; Audisio, Daniele ; Sacerdote, Paola ; Panerai, Alberto E. / Cholecystokinin, β-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls. In: Psychiatry Research. 1998 ; Vol. 78, No. 1-2. pp. 45-50.
@article{5efeb64e750948cbac10a976f0e74624,
title = "Cholecystokinin, β-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls",
abstract = "Cholecystokinin (CCK), β-endorphin (BE), and vasoactive intestinal peptide (VIP) in peripheral blood mononuclear cells from 30 drug-naive schizophrenics compared to 22 healthy controls were studied. Patients were evaluated with the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Positive Symptoms (SAPS) and the Scale for the Assessment of the Negative Symptoms (SANS) at baseline (TO), and after four weeks (T4) in nine patients who were subsequently treated with haloperidol (HL). Neuropeptide concentrations in peripheral blood mononuclear cells (PBMC) were measured at T0 and, for the treated patients, at T4. There was a negative correlation between CCK and SANS baseline scores and a trend for patients who responded poorly to HL (i.e. patients with a prevalence of negative symptomatology) to have lower CCK basal values.",
keywords = "β-Endorphin, Cholecystokinin, Haloperidol, Schizophrenia, Vasoactive intestinal peptide",
author = "Mauri, {Massimo C.} and Renata Rudelli and Stefano Vanni and Gabriele Panza and Aldo Sicaro and Daniele Audisio and Paola Sacerdote and Panerai, {Alberto E.}",
year = "1998",
month = "3",
day = "20",
doi = "10.1016/S0165-1781(97)00145-5",
language = "English",
volume = "78",
pages = "45--50",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Cholecystokinin, β-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls

AU - Mauri, Massimo C.

AU - Rudelli, Renata

AU - Vanni, Stefano

AU - Panza, Gabriele

AU - Sicaro, Aldo

AU - Audisio, Daniele

AU - Sacerdote, Paola

AU - Panerai, Alberto E.

PY - 1998/3/20

Y1 - 1998/3/20

N2 - Cholecystokinin (CCK), β-endorphin (BE), and vasoactive intestinal peptide (VIP) in peripheral blood mononuclear cells from 30 drug-naive schizophrenics compared to 22 healthy controls were studied. Patients were evaluated with the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Positive Symptoms (SAPS) and the Scale for the Assessment of the Negative Symptoms (SANS) at baseline (TO), and after four weeks (T4) in nine patients who were subsequently treated with haloperidol (HL). Neuropeptide concentrations in peripheral blood mononuclear cells (PBMC) were measured at T0 and, for the treated patients, at T4. There was a negative correlation between CCK and SANS baseline scores and a trend for patients who responded poorly to HL (i.e. patients with a prevalence of negative symptomatology) to have lower CCK basal values.

AB - Cholecystokinin (CCK), β-endorphin (BE), and vasoactive intestinal peptide (VIP) in peripheral blood mononuclear cells from 30 drug-naive schizophrenics compared to 22 healthy controls were studied. Patients were evaluated with the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Positive Symptoms (SAPS) and the Scale for the Assessment of the Negative Symptoms (SANS) at baseline (TO), and after four weeks (T4) in nine patients who were subsequently treated with haloperidol (HL). Neuropeptide concentrations in peripheral blood mononuclear cells (PBMC) were measured at T0 and, for the treated patients, at T4. There was a negative correlation between CCK and SANS baseline scores and a trend for patients who responded poorly to HL (i.e. patients with a prevalence of negative symptomatology) to have lower CCK basal values.

KW - β-Endorphin

KW - Cholecystokinin

KW - Haloperidol

KW - Schizophrenia

KW - Vasoactive intestinal peptide

UR - http://www.scopus.com/inward/record.url?scp=0032549835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032549835&partnerID=8YFLogxK

U2 - 10.1016/S0165-1781(97)00145-5

DO - 10.1016/S0165-1781(97)00145-5

M3 - Article

C2 - 9579701

AN - SCOPUS:0032549835

VL - 78

SP - 45

EP - 50

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 1-2

ER -